Japanese ophthalmology specialist Santen first established a China affiliate in 2005 and has grown very successfully in the past 14 years. GM of Santen Pharmaceutical (China) Co., Ltd. (hereafter, Santen China) Takayuki Yamada gives his first impressions of the Chinese market since his arrival in April 2019, Santen’s commitment to serving patients in China, key collaborations including their JV with local company Chongqing Kerui, and Santen’s commitment to growing and investing in China – so that Santen China can become the top affiliate for Santen globally.
In terms of the healthcare market, China is actually very similar to Europe, where the healthcare budget management deeply depends on each province
